| abstract |
Provided are anti-FGF19 antibodies that selectively target to N-terminus of fibroblast growth factor 19 (FGF19) and antigen-binding fragments thereof. Also provided are compositions and uses of said antibodies, as well as methods of treating a disease or disorder caused by or related to abnormal FGF19-FGFR4 signaling, e.g. cancer, by administering the anti-FGF19 antibodies. |